NeuroOne Medical Technologies Corporation (NMTC)

NMTC Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	24	21	27	47	28	25
Market Cap Growth	18.11%	-22.25%	-42.21%	67.28%	12.33%	-
Enterprise Value	22	16	16	41	26	25
PE Ratio	-	-1.80	-2.74	-4.76	-2.08	-3.72
PS Ratio	6.49	6.25	12.92	195.11	14.71	-
PB Ratio	6.28	3.41	2.85	7.23	13.72	-20.38
P/FCF Ratio	-2.57	-1.61	-3.51	-5.47	-7.99	-4.63
P/OCF Ratio	-2.63	-1.65	-3.64	-5.51	-8.27	-4.68
EV/Sales Ratio	5.84	4.70	7.72	167.53	13.27	-
EV/EBITDA Ratio	-2.30	-1.39	-1.68	-4.15	-4.23	-3.86
EV/EBIT Ratio	-2.24	-1.35	-1.64	-4.09	-4.18	-3.84
EV/FCF Ratio	-2.37	-1.21	-2.10	-4.69	-7.21	-4.58
Debt / Equity Ratio	-	0.01	0.01	0.03	0.61	-
Debt / EBITDA Ratio	-	0.00	-0.01	-0.02	-0.21	-
Debt / FCF Ratio	-	0.00	-0.02	-0.02	-0.36	-
Quick Ratio	1.94	2.97	3.61	5.88	1.71	0.15
Current Ratio	3.06	4.08	3.93	6.17	1.76	0.17
Asset Turnover	0.60	0.44	0.15	0.03	0.58	0
Interest Coverage	-	-	-	-3257.49	-0.81	-22.83
Return on Equity (ROE)	-277.70%	-198.70%	-81.10%	-143.80%	468.00%	450.20%
Return on Assets (ROA)	-204.30%	-154.40%	-71.90%	-105.90%	-411.10%	-519.50%
Return on Capital (ROIC)	-336.02%	-189.62%	-103.16%	-151.23%	-147.32%	469.74%
Earnings Yield	-52.91%	-55.68%	-36.50%	-20.99%	-48.14%	-26.88%
FCF Yield	-49.94%	-62.28%	-28.45%	-18.29%	-12.52%	-21.62%
Buyback Yield / Dilution	-57.85%	-13.27%	-49.56%	-97.52%	-37.01%	-79.39%
Total Shareholder Return	-57.85%	-13.27%	-49.56%	-97.52%	-37.01%	-79.39%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).